GENFIT Seeks $132 Million IPO to Support NASH Programs

Life Science

Aurora Cannabis chairman describes Nelson Peltz partnership, plans for consumer expansion

Cannabis, Life Science

CStone Approved to Start China Trial of HDAC6 Inhibitor

Life Science

CASI Pharma Signs Up CR Guokang Pharma to Distribute Evomela in China

Life Science

Siemens Overtakes Huawei as Biggest Patent Applicant in Europe

Technology

ZTE Corp Controlling Shareholder Plans 3 Percent Stake Sale After Stock Rebound

Technology

Regeneron/Sanofi wins U.S. approval for expanded use of skin drug

Life Science

BGI Genomics Pays $50 Million for China Rights to Natera Cancer Test

Life Science

Tencent, Tiger Global Lead USD57.9 Million Fundraising for E-Signature Services Firm Fadada

Technology

China regulator approves 95 new video games, including from Tencent, NetEase

Technology

China Finalizes IPO Listing Rules for Shanghai High-Tech Board

Life Science

China Unicom, Telefonica Partner on 5G Networks

Technology

Shanghai Henlius’ Rituxan Biosimilar is First Biosimilar Approved in China

Life Science

China’s Lenovo Sets Up JV With US Cloud Firm NetApp

Technology

Novartis gene therapy would be cost effective up to $900,000 -U.S. group

Life Science